Biodesix, Inc. P/S ratio

P/S ratio of BDSX for past 10 years: annual, quarterly and twelve month trailing (TTM) including P/S ratio growth rates and interactive chart. A valuation metric that measures the share price of a stock compared to its sales per share. It is used by investors mainly because it’s less volatile than P/E and less subject to accounting manipulation. A low P/S ratio compare to historical average or other companies in the same industry might indicate undervaluation.

Highlights and Quick Summary

Current P/S ratio of Biodesix, Inc. is 2.66 (as of December 31, 2021)
  • P/S ratio for the quarter ending September 30, 2022 was 1.43 (a -30.37% decrease compared to previous quarter)
  • Year-over-year quarterly P/S ratio decreased by -46.02%
  • Annual P/S ratio for 2021 was 2.66 (a 24.06% increase from previous year)
  • Annual P/S ratio for 2020 was 2.14 (a 1516.99% increase from previous year)
  • Annual P/S ratio for 2019 was 0.13 (a 0.0% decrease from previous year)
Visit stockrow.com/BDSX for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical P/S ratio of Biodesix, Inc.

Most recent P/S ratioof BDSX including historical data for past 10 years.

Interactive Chart of P/S ratio of Biodesix, Inc.

Biodesix, Inc. P/S ratio for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 – 1.43 2.06 1.63 –
2021 2.66 3.1 4.76 7.79 2.66
2020 2.14 0.13 0.13 0.13 2.14
2019 – – 0.13 0.13 0.13
2018 – – – – 0.13

Business Profile of Biodesix, Inc.

Sector: Healthcare
Industry: Diagnostics & Research
© stockrow.com